Chronic Fatigue Syndrome Trial, Recruiting NCT06614309 Sponsor: Mayo Clinic Condition: Chronic Fatigue Syndrome
Back to Chronic Fatigue Syndrome

Chronic Fatigue Syndrome Trial, Recruiting

NCT06614309
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You speak English
  • You have been diagnosed with Long COVID

Who may not be able to join:

  • You have ever had a tear in a coronary artery or the main artery leaving your heart (coronary artery dissection or aortic dissection)
  • You have ever had a neurological condition such as dementia, Alzheimer's disease, or another brain-related illness
  • You have ever had a stroke or disease affecting the blood vessels in the brain
  • You have ever had an aneurysm (a dangerous bulge in a blood vessel)
  • You currently have moderate to severe chronic obstructive pulmonary disease (a serious lung condition)
  • You currently have moderate to severe asthma that is not well controlled
  • You currently have moderate to severe bronchiectasis (a long-term lung condition affecting the airways)
  • You currently have moderate to severe scarring or inflammation of the lungs that requires extra oxygen
  • You currently need supplemental (extra) oxygen for any reason
  • You are currently experiencing new or worsening heart failure symptoms
  • You currently have right-side heart disease caused by a chronic lung condition or sleep apnea
  • You currently have uncontrolled reduced blood flow to the heart or chest pain (angina)
  • You currently have uncontrolled irregular heart rhythms
  • You currently have an infection of the heart or lungs, such as myocarditis or pericarditis
  • You currently have a significant blockage in a specific major heart artery (left main coronary artery)
  • You currently have moderate to severe narrowing of the aortic heart valve
  • You currently have blood clots in the lungs or related conditions
  • You currently have severe breathing difficulties
  • You currently have chronic kidney disease
  • You currently have chronic liver disease
  • You are a woman of childbearing age who is pregnant (a urine pregnancy test will be done at the first visit to check)
  • Your body mass index (BMI) is over 40
  • The study equipment is unable to get a clear enough reading of blood flow in your brain (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Courtney Wheatley-Guy, Mayo Clinic

Phone: 480-301-6616

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
24 September 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in cerebral blood flow; Change in heart rate variability; Change in brain fog scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov